TLR4 and inflammation: In conclusion, IGU ameliorates BLM-induced pulmonary inflammation in mice by blocking the TLR4/NFκB pathway, suppressing macrophage activation, and preventing M1 macrophage polarization, thereby reducing PF caused by the polarization of M2 macrophages and EMT in the advanced stage (Figure 9).